US equities |
NVDA $204.64 ▼-4.22% INTC $65.76 ▼-28.58% MU $884.74 ▼-5.30% AMZN $240.35 ▼-1.41% AAPL $344.63 ▼-1.23% SNDK $1,150.89 ▼-13.47% AMD $504.80 ▼-10.88% MSFT $521.91 ▼-1.55%
FinancialContent

Articles published by Nkarta, Inc.

News headline image
Nkarta to Participate in September Investor Conferences
From Nkarta, Inc.
Via GlobeNewswire
Tickers NKTX
News headline image
Nkarta to Present Initial Autoimmune Clinical Data for NKX019 at American College of Rheumatology (ACR) Convergence 2026
From Nkarta, Inc.
Via GlobeNewswire
Tickers NKTX
News headline image
Nkarta Reports Second Quarter 2026 Financial Results and Corporate Highlights
From Nkarta, Inc.
Via GlobeNewswire
Tickers NKTX
News headline image
Nkarta to Participate in H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
From Nkarta, Inc.
Via GlobeNewswire
Tickers NKTX
News headline image
Nkarta Reports First Quarter 2026 Financial Results and Corporate Highlights
From Nkarta, Inc.
Via GlobeNewswire
Tickers NKTX
News headline image
Nkarta Announces FDA Agreement on Outpatient Dosing of NKX019 in Autoimmune Disease, Expanding Access to Community Rheumatology Centers
From Nkarta, Inc.
Via GlobeNewswire
Tickers NKTX
News headline image
Nkarta to Participate in Needham Virtual Healthcare Conference
From Nkarta, Inc.
Via GlobeNewswire
Tickers NKTX
News headline image
Nkarta Reports Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights
From Nkarta, Inc.
Via GlobeNewswire
Tickers NKTX
News headline image
Nkarta to Participate in March Investor Conferences
From Nkarta, Inc.
Via GlobeNewswire
Tickers NKTX
News headline image
Nkarta to Participate in Evercore Healthcare Conference
From Nkarta, Inc.
Via GlobeNewswire
Tickers NKTX
News headline image
Nkarta Reports Third Quarter 2025 Financial Results and Corporate Highlights
From Nkarta, Inc.
Via GlobeNewswire
Tickers NKTX
News headline image
Nkarta to Participate in November Investor Conferences
From Nkarta, Inc.
Via GlobeNewswire
Tickers NKTX
News headline image
Nkarta Announces Poster Presentation at Upcoming American College of Rheumatology (ACR) Convergence Meeting
From Nkarta, Inc.
Via GlobeNewswire
Tickers NKTX
News headline image
Nkarta Reports Second Quarter 2025 Financial Results and Corporate Highlights
From Nkarta, Inc.
Via GlobeNewswire
Tickers NKTX
News headline image
Nkarta Appoints Shawn Rose Chief Medical Officer & Head of R&D as Company Resets Senior Leadership Role for Autoimmune Focus
From Nkarta, Inc.
Via GlobeNewswire
Tickers NKTX
News headline image
Nkarta Reports First Quarter 2025 Financial Results and Corporate Highlights
From Nkarta, Inc.
Via GlobeNewswire
Tickers NKTX
News headline image
Nkarta Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights
From Nkarta, Inc.
Via GlobeNewswire
Tickers NKTX
News headline image
Nkarta Announces IND Clearance of Investigator-Sponsored Trial in Myasthenia Gravis and Opening of Enrollment for Ntrust-2
From Nkarta, Inc.
Via GlobeNewswire
Tickers NKTX
News headline image
Nkarta Reports Third Quarter 2024 Financial Results and Corporate Highlights
From Nkarta, Inc.
Via GlobeNewswire
Tickers NKTX
News headline image
Correction: Nkarta Reports Second Quarter 2024 Financial Results and Corporate Highlights
From Nkarta, Inc.
Via GlobeNewswire
Tickers NKTX
News headline image
Nkarta Reports Second Quarter 2024 Financial Results and Corporate Highlights
From Nkarta, Inc.
Via GlobeNewswire
Tickers NKTX
News headline image
Nkarta Announces Leadership Updates, Appoints Nadir Mahmood as President
From Nkarta, Inc.
Via GlobeNewswire
Tickers NKTX
News headline image
Nkarta Initiates Clinical Trial of NKX019 in Lupus Nephritis with First Patient in Screening and Announces Pipeline Expansion to Additional Autoimmune Indications
From Nkarta, Inc.
Via GlobeNewswire
Tickers NKTX
News headline image
Nkarta Reports First Quarter 2024 Financial Results and Corporate Highlights
From Nkarta, Inc.
Via GlobeNewswire
Tickers NKTX
News headline image
Nkarta Announces Pricing of $240 Million Underwritten Offering
From Nkarta, Inc.
Via GlobeNewswire
Tickers NKTX
News headline image
Nkarta Presents NKX101 Clinical Data at the 2023 American Society of Hematology Annual Meeting & Exposition
From Nkarta, Inc.
Via GlobeNewswire
Tickers NKTX
News headline image
Nkarta Reports Third Quarter 2023 Financial Results and Corporate Highlights
From Nkarta, Inc.
Via GlobeNewswire
Tickers NKTX
News headline image
Nkarta Receives FDA Clearance of IND Application for NKX019 in Lupus Nephritis
From Nkarta, Inc.
Via GlobeNewswire
Tickers NKTX
News headline image
Nkarta to Host Conference Call on Tuesday, October 17 at 8am ET to Discuss Expansion of Clinical Pipeline and Organizational Cost Measures
From Nkarta, Inc.
Via GlobeNewswire
Tickers NKTX
News headline image
Nkarta Reports Second Quarter 2023 Financial Results and Corporate Highlights
From Nkarta, Inc.
Via GlobeNewswire
Tickers NKTX